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Abstract
Background/Aim. Left ventricular noncompaction (LVNC)
is a disorder in endomyocardial morphogenesis, seen either
isolated (in the absence of other cardiac anomalies) or in asso-
ciation with congenital heart disease and some neuromuscular
diseases. Intrauterine arrest of the compaction of myocardial
fibers is postulated to be the reason of LVNC. Recognition of
this condition is extremely important due to its high mortality
and morbidity that lead to progressive heart failure, ventricular
arrhythmias and thromboembolic events. The aim of this
study was to determine the prevalence and clinical presenta-
tion of LVNC among consecutive outpatients according to
clinical and echocardiographyic findings. Methode. A total of
3,854 consecutive patients examined at the Institute for Car-
diovascular Diseases within a period January 2006 – January
2007 were included in the study. All the patients underwent
echocardiographic examination using the same equipment
(Vivid 7, GE Medical System). Echocardiographic parameters
and clinical presentation in patients with echocardiographic
criteria for LVNC were analyzed. Results. Analyzing 3,854
consecutive  outpatients, using two-dimensional Color Dop-
pler echocardiography from January 2006 to January 2007, 12
patients met the criteria for LVNC. Seven of them were male.
The mean age at diagnosis was 45 ± 15 years. Analyzing clini-
cal manifestation of LVNC it was found that seven patients
had signs of heart failure, six had arrhythmias with no embolic
events. Conclusion. Our results suggest that the real preva-
lence of LVNC may be higher than expected. New studies
have to be done to solve this problem.
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Apstrakt
Uvod/Cilj. Nedovoljno formiran miokard leve komore (left
ventricular noncompaction – LVNC) je poremećaj endomiokardi-
jalne morfogeneze koji se viđa izolovan (u odsustvu drugih sr-
čanih anomalija) ili udružen sa kongenitalnim srčanim obolje-
njem i nekim neuromuskularnim bolestima. Smatra se da je in-
trauterini zastoj u formiranju miokardnih vlakana razlog za
LVNC. Zbog visokog mortaliteta i morbiditeta koji vodi ka
progresivnoj srčanoj slabosti, ventrikularnim aritmijama i trom-
boembolijskim događajima, prepoznavanje ovog stanja je veo-
ma važno. Cilj rada bio je da se utvrde prevalencija i klinička
prezentacija LVNC kod ehokardiografski pregledanih bolesni-
ka. Metode. Ovom prospektivnom studijom obuhvaćeno je
3 854 bolesnika, koji su sukcesivno pregledani u Institutu za
kardiovaskularne bolesti „Dedinje” tokom jedne godine (januar
2006–januar 2007). Pregled je vršen dvodimenzionalnim kolor
dopler ultrazvučnim aparatom (Vivid  7, GE Medical system).
Analizirani su ehokardiografski parametri i kliničke karakteristi-
ke bolesnika kojima je ehokardiografskim pregledom ustanov-
ljen LVNC. Rezultati. Analizom podataka o 3 854 uzastopno
pregledana bolesnika od januara 2006. do januara 2007. godine,
utvđeno je da je 12 bolesnika ispunjavalo kriterijume za LVNC.
Prosečno životno doba bolesnika bilo je 45 ± 15 godina; sedam
bolesnika bilo je muškog pola. Znake srčane slabosti imalo je
sedam bolesnika, šest bolesnika je imalo aritmije, a tromboem-
bolijski događaji nisu registrovani. Zaključak. Rezultati našeg
ispitivanja ukazuju na to da prevalencija LVNC može biti viša
od očekivane. Potrebne su nove studije o LVNC koje će rešiti
taj problem.
Ključne reči:
srce, kongenitalne mane; disfunkcija leve komore;
ehokardiografija; dijagnoza; prevalenca.
Introduction
Noncompaction of the left ventricle (LVNC) was an
unclassified cardiac abnormality until the year 2006 when
according to the new Contemporary Definitions and Classifi-
cation of the Cardiomyopathies it was classified as primary
cardiomyopathy with genetic cause leading to an arrest in
intrauterine endomyocardial morphogenesis 
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that pathogenesis of this cardiomyopathy is unknown, but
two hypotheses have been proposed: congenital and ac-
quired. The first one was performed due to the arrest of an in-
trauterine compaction of the myocardial fibers in the absence
of any other structural heart diseases. The mechanism of the
second hypothesis was less convincing than the first one and it
was described as based on higher hemodynamics demands in
some situations (left ventricular pressure or volume overload),
which could change endomyocardium 
4. However, arguments
supporting the genetic cause of LVNC frequently include as-
sociation of LVNC with congenital cardiac abnormalities
(mutations in α-dystrobrevin gene and transcription factor
NKX2.5), familiar occurrences of this disease, mitochondrial
mutations and X-linked inheritance and other genetics disor-
ders (Barth syndrome in neonates) 
1, 2.
Validation of the well-known disorder was the first case
of this abnormality, which was described in 1932 in the
newborn with aortic atresia and coronary-ventricular fistula
5. Since then, we were able to find publications where myo-
cardium was described as a “spongy myocardium” in animal
and human beings 
6, 7. There are two forms of this abnormal-
ity: an isolated and nonisolated where the difference depends
on the presence of other cardiac abnormalities 
8. The first
case, without any other morphogenetic cardiac abnormality,
was described in 1984 in a form of the persistence of isolated
myocardial sinusoids 
9.
Noncompaction of the left ventricular myocardium is an
uncommon finding and remains frequently overlooked even
by experienced echocardiographers. The natural history
  of
LVNC is largely unresolved but includes left ventricular
systolic dysfunction
 and heart failure (in some cases heart
transplantation),
  diverse forms
  of remodeling, arrhythmias,
sudden death, and thromboembolic events. There are studies
showing that patients with LVNC would not have poor prog-
nosis if we detected them and started with the treatment ear-
lier 
9, 10.
The aim of this study was to determine the frequency
and the clinical presentation of LVNC among consecutive
outpatients in the one-year period, according to clinical and
echocardiographic findings, and to find out if there are any
similarities among them.
Methods
We performed transthoracic echocardiography and
other necessary exams to all consecutive  outpatients who
came to our Institute from January 2006 to January 2007.
After initial clinical assessment (detailed medical history
using standard questionnaires, physical exam), all the outpa-
tients were classified according to the probability of having
coronary artery disease, valvular heart disease, cardiomy-
opathies or electrophysiological abnormalities. These pa-
tients were sent to our echocardiography laboratory for fur-
ther evaluation of their condition. The echocardiography
exam was performed by a Vivid 7, GE Medical System. In
this study four physicians (who applied echocardiography
routinely in our Institution) were involved. Echocardio-
graphic diagnostic criteria include: the noncompacted endo-
cardial layer, which is thicker than the compacted epicardial
layer (ratio of noncompacted/compacted ≥ 2) and consists of:
prominent and excessive trabeculations (more than three),
and deep recesses filled with blood from the ventricular cav-
ity visualized on color doppler imaging 
1–8. A complete two-
dimensional and Doppler echocardiography examination was
performed in all patients according to the recommendations
of the American Society of Echocardiography 
9. Left ven-
tricular ejection fraction was calculated using the biplane
area length method. The left ventricular wall was divided
into 17 segments to describe the location of the noncom-
pacted segments: the whole apex was one segment, apical
segments (included apical thirds) of the anterior, septal, lat-
eral, inferior walls and basal or middle parts of the anterior,
anteroseptal, anterolateral, inferior, inferoseptal, inferolateral
walls. Diastolic function was measured in the left ventricular
inflow pattern at the tip of the mitral valve leaflets. Diastolic
function was graded as follows: normal, abnormal relaxation,
pseudonormal or restrictive pattern.
Results
Within a year, from January 2006 to January 2007, we
performed 3,854 consecutive outpatient studies by 2D echo-
cardiography. LVNC criteria were determined in 12 patients
(0.31%). Seven of them were men. The mean age of the pa-
tients at diagnosis was 45 ± 15 years (Table 1). The transtho-
racic echocardiographic parameters pointed out border line
enlargement of the left side cavities and in the half of the pa-
tients, ejection fraction were impaired (Table 1).
Table 1
Clinical and LV еchocardiographic (ECG) characteristics of
12 patients with left ventricular noncompaction (LVNC)
Clinical and LV ECG characteristics Values
Age (year), ґ ± SD 45 ± 15
Men, n (%) 7 (58%)
Angina pectoris/infarction, n (%) 3 (25)
Familial occurrence of LVNC no presence
Functional class I/II, n (%) 5 (42)
Functional class III/IV, n (%) 7 (58)
EDD (mm), ґ ± SD 56 ± 6
ESD (mm), ґ ± SD 40 ± 8
Left atrium (mm), ґ ± SD 40 ± 16
Mitral regurgitation (mild/severe), n (%) 5 (42)
Ejection fraction normal, n (%) 3 (25)
Impaired ejection fraction (< 30%), n (%) 6 (50)
Impaired relaxation of LV, n (%) 7 (58)
Restrictive pattern of LV, n (%) 2 (28)
EDD – end-diastolic dimension; ESD– end-systolic dimension;
LV – left ventricle
The previous exams were initially performed in other
regional hospitals or private cardiology practice. In our study
the true diagnosis of this abnormality was determined on the
first visit, but only in three patients. On the other hand, there
were 75% of those who were with at least one or two previ-
ously determined diagnoses, which were not related to
LVNC. One of these three patients, which were mentioned
previously with the exact initial diagnosis, had symptomsStrana 34 VOJNOSANITETSKI PREGLED Volumen 69, Broj 1
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and it was predominantly palpitation and chest discomfort on
effort. We performed a 24-hour Holter monitoring, which
showed nonsustained ventricular tachycardia. 2D echocardi-
ographic exam showed normal left cavity dimensions, mitral
valve prolapse with moderate to severe mitral regurgitation
and normal ejection fraction. The second patient, from the
same group, was the oldest patient (69 year old) who had
some lung problems probably caused by tuberculosis (not
definitely diagnosed) and normal left cavity size with no-
compaction segments and impaired systolic function (ejec-
tion fraction 40%) (Figure 1A). The third patient did not
have systolic dysfunction or any other heart problems (valve
disease, arrhythmias, etc.) except moderate effort on exercise
(Figure 1B). In the group of patients who were first misinter-
preted, the diagnosis was based on the clinical exams,
symptoms, signs of various morphological (structural) ab-
normalities based on echocardiography exams or electro-
physiological disturbances. Accordingly, two patients with
severe mitral valve regurgitation were sent to our Institution to
be followed up to the time of operation. The first one of these
patients had dilatation of mitral annulus caused by cardiomy-
opathy of “unknown” cause with impaired systolic function
(ejection fraction 30%). The next patient had prolapse of the
anterior mitral leaflet with enlarged left ventricle dimensions
and still not impaired systolic function (Figure 1C). These two
patients had atrial fibrillation at the beginning.
According to the guidelines for valvular heart disease, 3
patients in these two groups (true diagnosis or misdiagnosis)
were operated (they were implanted artificial mechanical
prosthesis in mitral position). In operated patients, before
valve replacement, coronarography was done and found non-
significant stenosis in coronary arteries. Eleven month after
operation, due to cardiac arrest caused by sustained ven-
tricular tachycardia and successful cardiopulmonary resus-
citation, cardioverter defibrillators (ICD) were implanted in
the first patient. A year and a half after the operation, non-
sustaine ventricular tachycardia was registered in the second
patient and it was decided that after amiodarone loading he
would be included in electrophysiological study. The third
patient had nonsustained ventricular tachycardia before and
after the operation (first true diagnosis group). In the group
of the next five patients with the signs of heart failure, (the
New York Heart Association NYHA) III or IV, 2 patients
felt better thanks to drugs (NYHA II) and 3 patients had
some of electrophysiological interventions (2 pacemakers, 1
of them was ICD and 1 ablation), resulting in improvement
in functional classes (Figure 1D). One of the last 2 patients
had myocardial infarction with occlusion of the right coro-
nary artery and nonsignificant stenosis in other coronary ar-
teries and the second patient had systolic and diastolic dys-
function without symptoms.
Analyzing clinical manifestation of LVNC, it was
found that 8 patients had signs of heart failure (67%), 7
(58%) arrhythmias (Table 2), 11 ECG abnormality (91%)
with no embolic complication.
The most frequent distribution of noncompaction seg-
ments, as already known, were in the apex and in the apical
and middle parts of septum, lateral and posterior walls (Fig-
ure 2).
We did not find familiar occurrence of LVNC at our
patients group, according to their anamnesis, because of fre-
quent refusal of their relatives to allow us to determine the
status of their present condition, as well. In only 6 cases, we
succeeded to make echocardiography in the first relatives,
who agreed to be checked up, and these exams were within
normal range.
A
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Fig. 1 – A) A 70-year-old patient with normal left ventricle
cavity size and impaired ejection fraction: 3-chamber view
shows deep recesses in the apical third of posterior wall;
B) Rutine echocardiography exam in a 37-year-old patient
before operative treatment of breast tumor (parasternal
short axis vies shows hypertrabeculisation in basal
segments of inferior, posterior and lateral walls of the left
ventricule); C) Parasternal short axis view shows
meshwork in the middle ventricule segments of inferior,
posterior and lateral walls in a 36-year-old patient with
mitral valve prolapsis, normal sistolic function and a non-
sustained ventricular tachycardia; D) Four-chamber view
clearly shows deep recesses with intertrabecular spaces in
the apex and in the lateral wall in a 28-year-old female on
whom ablation of atrial fibrillation was perfomed
Table 2
Electrocardiographic (ECG) abnormalities in 12 patients
with left ventricular noncompaction
ECG abnormalities Number of patients
Chronic atrial fibrillation 4
Ventricular tahycardia 3
Left bundle branch block 3
Premature ventricular contraction 3
High grade atrioventricular (AV) block 1Volumen 69, Broj 1 VOJNOSANITETSKI PREGLED Strana 35
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Fig. 2 – Distribution of noncompaction segments of the left
ventricular myocardium in our study
Discussion
Although LVNC is a recently recognized
  congenital
cardiomyopathy, there are publications which instruct us to
make better diagnosis of this disorder in our daily, routine
practice 
11, 12. The prevalence of LVNC has been reported to
be from 0.05% to 0.24% in the largest adult series and 0.14%
in the largest pediatric series, but according to our results
(0.31%) the real prevalence is thought to be higher 
13, 14. No
data are available on the prevalence of LVNC from autopsy
series 
15. The real prevalence of LVNC and determination of
this value in specific groups (health population, hospital
population, patients with cardiomyopathies, etc) is not really
known. In population there is a lack of interest for determi-
nation of their present health condition during the time when
they are without any symptoms. The diagnosis of LVNC
could be made with two-dimensional Doppler echocardi-
ography, cardiac
 magnetic resonance imaging, cardiac com-
puted tomography, left ventricular angiography, after cardiac
transplantation or autopsy 
16. Echocardiography is the most
available technique for diagnosing and following-up of pa-
tients with LVNC 
17–19. Older echocardiographic machines
and still “new” entities would cause a risk in sense of misin-
terpretations or misdiagnosis. During primary echocardio-
graphic investigations, LVNC was diagnosed in approxi-
mately less than 50% of patients 
17, though this percentage in
our study was much higher (75%). The most frequently
misinterpreted were apical or localized hypertrophic cardio-
myopathy, dilated cardiomyopathy, endocardial fibroelasto-
sis, endomyocardial fibrosis, restrictive cardiomyopathy,
myocarditis, left ventricular masses or thrombus and some
other myocardial or pericardial disease. The misinterpreta-
tions in our study group included apical hypertrophic car-
diomyopathy (n = 1), dilated cardiomyopathies (n = 7) and as
the new and distinctive – patients with primary mitral valve
pathology (n = 3). The reason we substantially report LVNC
when the ventricular dilatation occurs is the low possibility
to visualize deep hypertrabeculation in hypertrophied myo-
cardium with poor function.
The false diagnose of LVNC, might include false ten-
dons, aberrant bands, thrombus which are frequently seen or
obliterate processes of the left ventricle cavity, intramyocardial
hematomas, cardiac metastases and intramyocardial abscesses
which are very rare 
12, 14, 16, 17. We should be aware that an
overlap exists between different cardiac abnormalities, which
might be mixed up or associated with the LVNC 
12.
If we look for available data for prognosis in this group,
we will see that the first studies 
20–22 reported high morbidity
and mortality rate because physicians did not recognize this
pathology and according to that, they made the diagnosis rela-
tively late. The longest follow-up period of patients with
LVNC was 24 years and it demonstrated that some patients
could have a favorable prognosis 
15. If we have to evaluate
status of these patients at the time of diagnoses and during
following-up period, we would see that there were some con-
trarieties. The latest studies, which included a great number of
patients, suggesting that noncompaction alone does not seem
to be a risk factor for malignant supraventricular or ventricular
arrhythmias. At the beginning, in our group of patients, 58%
had a kind of arrhythmias and not all of these patients had
systolic dysfunction. We would like to suggest that at the first
visit it has to be predominantly evaluation of the patients with
arrhythmias or ECG abnormalities (apart from the presence of
systolic dysfunction or not) and the patients with valvular heart
disease, not just aortic stenosis which has been already pub-
lished, when patients with mitral insufficiency (caused by mi-
tral valve prolapse) have to be focused on, before occurring of
systolic dysfunction or dilatation 
11, 23, 24. New medical treat-
ment options could change life risk by treating arrhythmias, as
well as to lead to the improvements in drugs selection and pos-
sibility to have new and accessible procedures that could
change both length and quality of life. The pitfalls in the diag-
nosis of LVNC are still present and it could challenge physi-
cians to put effort in new etiology investigations and on better
diagnostics imaging techniques 
11, 12.
Conclusion
Although many cardiologists have focused on LVNC,
there is no genuine data about prevalence of this abnormal-
ity. This study points out different initial signs and symptoms
and very widely variation of treatment possibilities. New
studies in this field are necessary to make this problem easier
for understanding and to provide a required information to
physicians who perform echocardiography for better diag-
nostics of this disease in the future, because it is very impor-
tant to start treating these patients in their oligosymptomatic
or asymptomatic period.
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